Immunomodulatory Gene Therapy in Lysosomal Storage Disorders

E-ISSN： 1875-5631|9|6|503-510

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.9, Iss.6, 2009-12, pp. : 503-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for lysosomal storage diseases

By Daly T.M. Sands M.S.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 10, 1998-10 ,pp. : 1673-1682

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Lysosomal Storage Disorders: Progress with Enzyme Replacement Therapy

By Rohrbach Marianne Clarke Joe T.R.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2697-2716

Adis International

Access to resources Recommend Favorite

Enzyme therapy for the lysosomal storage disorders: principles, patents, practice and prospects

By Pastores Gregory M

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1157-1172

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2558-2574

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for lysosomal storage disorders: developing insights

By van Gelder Carin M Vollebregt Audrey AM Plug Iris van der Ploeg Ans T Reuser Arnold JJ

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2281-2299

Informa Healthcare

Access to resources Recommend Favorite